Background: Recent experimental studies suggest that currently used anesthetics have neurotoxic effects on young animals. Clinical studies are increasingly publishing about the effects of anesthesia on the long‐term outcome, providing contradictory results. The selective alpha‐2 adrenergic receptor agonist dexmedetomidine has been suggested as an alternative nontoxic sedative agent. Aims: The aim of this systematic review was to assess the potential neuroprotective and neurobehavioral effects of dexmedetomidine in young
Concern over potential neurotoxicity of anesthetics has led to growing interest in prospective clini...
Damage caused by administering general anesthetics to the developing brain in young children and pre...
Introduction: general anesthetics are involved in neuroprotection in adults after ischemic events an...
Background: Structural brain abnormalities in newborn animals after prolonged exposure to all routin...
OBJECTIVE: To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative a...
Preclinical evidence suggests that anesthetic agents harm the developing brain thereby causing long-...
Background: Brain injury in newborn animals from prolonged anaesthetic exposure has raised concerns ...
Numerous studies have demonstrated that general anesthetics might damage the nervous system, thus, t...
BACKGROUND: Our aim was to characterize the pharmacokinetics and sedative effects of intranasally (I...
Background and objectives: To update and review the application of dexmedetomidine in anesthesia and...
The long-term cerebral effects of general anaesthesia at the extremes of age are currently enjoying ...
Dexmedetomidine, selective α2-adrenergic agonist dexmedetomidine, has been widely used clinically fo...
Dexmedetomidine is a highly selective agonist of α2-receptors with sedative, anxiolytic, analgesic, ...
All commonly used general anesthetics have been shown to cause neurotoxicity in animal models, inclu...
Background: There are many animal studies demonstrating increased neuroapoptose in the first periods...
Concern over potential neurotoxicity of anesthetics has led to growing interest in prospective clini...
Damage caused by administering general anesthetics to the developing brain in young children and pre...
Introduction: general anesthetics are involved in neuroprotection in adults after ischemic events an...
Background: Structural brain abnormalities in newborn animals after prolonged exposure to all routin...
OBJECTIVE: To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative a...
Preclinical evidence suggests that anesthetic agents harm the developing brain thereby causing long-...
Background: Brain injury in newborn animals from prolonged anaesthetic exposure has raised concerns ...
Numerous studies have demonstrated that general anesthetics might damage the nervous system, thus, t...
BACKGROUND: Our aim was to characterize the pharmacokinetics and sedative effects of intranasally (I...
Background and objectives: To update and review the application of dexmedetomidine in anesthesia and...
The long-term cerebral effects of general anaesthesia at the extremes of age are currently enjoying ...
Dexmedetomidine, selective α2-adrenergic agonist dexmedetomidine, has been widely used clinically fo...
Dexmedetomidine is a highly selective agonist of α2-receptors with sedative, anxiolytic, analgesic, ...
All commonly used general anesthetics have been shown to cause neurotoxicity in animal models, inclu...
Background: There are many animal studies demonstrating increased neuroapoptose in the first periods...
Concern over potential neurotoxicity of anesthetics has led to growing interest in prospective clini...
Damage caused by administering general anesthetics to the developing brain in young children and pre...
Introduction: general anesthetics are involved in neuroprotection in adults after ischemic events an...